Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
242 FOLLOWERS
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA, and the broader pharma industry, including manufacturing, marketing finance.s, and beyond. We aim to analyze the day's news, showing readers not only what they need to know, but why they need to know it.
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
2d ago
AbbVie starts open casting call for next faces of Botox ads, doubling down on pitch to everyday users ntaylor Wed, 04/24/2024 - 06:04 ..read more
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
2d ago
AstraZeneca and Merck's Lynparza set to 'dominate' PARP market as it looks to grow cancer offerings with 100-plus ongoing trials badams Wed, 04/24/2024 - 04:52 ..read more
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
2d ago
Day One takes on Novartis with FDA nod for Ojemda in broader common childhood brain tumor use aliu Tue, 04/23/2024 - 22:15 ..read more
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
2d ago
Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche: Evaluate zbecker Tue, 04/23/2024 - 17:34 ..read more
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
2d ago
Vertex jumps to TreeFrog to enhance production of Type 1 diabetes cell therapy candidates kdunleavy Tue, 04/23/2024 - 16:40 ..read more
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
2d ago
Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs aliu Tue, 04/23/2024 - 15:46 ..read more
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
2d ago
Eli Lilly inks deal to acquire Nexus manufacturing plant in Wisconsin as Mounjaro and Zepbound shortages drag on fkansteiner Tue, 04/23/2024 - 15:10 ..read more
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
2d ago
New kid on The Bloc: Ogilvy, McCann alum Eduardo Basque joins as associate creative director apark Tue, 04/23/2024 - 11:25 ..read more
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
2d ago
Another delay for Abeona's topical gene therapy pz-cel as FDA sends out a rejection kdunleavy Tue, 04/23/2024 - 11:04 ..read more
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader phar
2d ago
Life sci consulting firm Santander launches with offer of commercial strategy guidance apark Tue, 04/23/2024 - 10:27 ..read more